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Abstract 
Introduction:Diabetes mellitus is a dangerous disease with complications and prevalence of mortality accounting 
for at least 10% of total health care A few published reports of both in vitro and in vivo studies on the interactions 
among Zinc (Zn), Alkaline- phosphatase (AP) enzyme activity, Ascorbic acid (AA) and glucose drew attention to 
their alterations in diabetic statesThe present work was aimed at evaluating the serum Zinc, Alkaline phosphatase 
and Ascorbic acid levels in Diabetes Mellitus and to statistically correlate the serum values of blood glucose with 
serum zinc, alkaline phosphatase [ALP] & Ascorbic acid [AA] for finding significance which could help in clinical 
outcome. Methods:  The sample size taken was 94 having both males and females of 22-85 years of age. The study 
group was divided into the following six categories. Group A: - Control group of 20 normal subjects in the age 
group of 22-70 years,      Group B: -14 IDDM without complication subject in the age group of 22-43 years.Group 
C: -20 IDDM with nephropathy subject in the age group of 41-85 years. Group D: - 20 NIDDM without 
complication subject in age group of 37-72 years.Group E:-10 NIDDM with nephropathy subject in age group of 45-
65 years.Group F:-10 NIDDM with retinopathy subject in age group of 49-66 years. Some parameters were taken 
from each individual of this study like estimation of blood glucose [fasting and post prandial] by Asatoor and King 
method, determination of serum Zn was carried out using atomic absorption spectrophotometry, Serum alkaline 
phosphatase (AP) activity was determined by the method of King and Armstrong as modified by Kind and King, 
plasma ascorbic acid is determined using formulae Results:The decrease in serum AA levels and the increase in 
serum DHA were highly significant. However, no correlations could be demonstrated statistically among the above 
said parameters in healthy and diabetic subjects.. It is being speculated that the raised serum AP activity may be due 
to the de-inhibition of activity by lowered serum AA concentrations. Serum Alkaline Phosphatase activity is 
eliminated in diabetics. It is an indicator of liver function that may be hampered in long term in diabetics. Serum 
Ascorbic acid is an antioxidant and its levels are decreased in diabetics. Its values can be assayed for monitoring 
oxidative reaction in diabetics. The estimation of serum zinc is not needed as there is no statistical difference. The 
need for right eating, exercise and right thinking needs to be stressed, particularly for diabetics. 
Keywords: NSAIDs, severe cutaneous adverse reactions (SCARs), cutaneous adverse drug reactions (CADRs), 
stevens johnson syndrome (SJS), fixed drug eruptions (FDEs), fixed dose combination (FDC), over the counter 
(OTC) 
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The prevalence of diabetes is rising all over the world 
due   to population  growth , aging, urbanization and an 
increase of obesity and physical inactivity. The urban-
rural divide in prevalence is narrowing as urbanization 
is spreading widely, adversely affecting the lifestyle of 
populations. Unlike in the West, where older persons 
are most affected, diabetes in Asian countries is 
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disproportionately high in young to middle-aged adults 
. At present, 80% of the worlds’ population with 
diabetes lives in low- and middle-income 
countries[1,2]. Diabetes mellitus is primarily a 
metabolic disorder arising from a lack of or resistance 
to insulin, which results in the impairment of uptake 
and storage of glucose and its reduced glucose 
utilization for energy purposes leading to the condition 
called hyperglycemia. Even the continuous insulin 
administration may not be as efficient as the 
functioning β-cells and complications often arise 
during long periods of time; these may be due to 
insulinopenia, hyperglycemia or other factors acting 
alone or in concert. Diabetes mellitus is also associated 
with premature micro vascular disease which 
contributes importantly to complications such as 
retinopathy and nephropathy[3,4].A few published 
reports of both in vitro and in vivo studies on the 
interactions among Zinc (Zn), Alkaline- phosphatase 
(AP) enzyme activity, Ascorbic acid (AA) and glucose 
drew attention to their alterations in diabetic states. 
These were reviewed and since relatively few reports 
existed with special reference to diabetes it was 
proposed to carry out a preliminary study of their levels 
in the blood of the diabetic as well as healthy subjects 
for their likely correlations and implications. The 
present work was aimed at evaluating the serum Zinc, 
Alkaline phosphatase and Ascorbic acid levels in 
Diabetes Mellitus and to statistically correlate the 
serum values of blood glucose with serum zinc, 
alkaline phosphatase [ALP] & Ascorbic acid [AA] for 
finding significance which could help in clinical 
outcome. 
Materials and methodology 
This study on serum zinc, alkaline phosphatase activity 
and ascorbic acid levels in diabetes was conducted in 
sample size of 94 of which a control group and 
experimental groups were divided.  
Materials: - The sample size taken was 94 having both 
males and females of 22-85 years of age. The study 
group was divided into the following six categories. 
Group A: - Control group of 20 normal subjects in the 
age group of 22-70 years,      Group B: -14 IDDM 
without complication subject in the age group of 22-43 
years. 
Group C: -20 IDDM with nephropathy subject in the 
age group of 41-85 years. Group D: - 20 NIDDM 
without complication subject in age group of 37-72 
years. 
Group E:-10 NIDDM with nephropathy subject in age 
group of 45-65 years. 
Group F:-10 NIDDM with retinopathy subject in age 
group of 49-66 years. 
METHODOLOGY:- Some parameters were taken 
from each individual of this study like estimation of 
blood glucose [fasting and post prandial] by Asatoor 
and King method, determination of serum Zn was 
carried out using atomic absorption spectrophotometry, 
Serum alkaline phosphatase (AP) activity was 
determined by the method of King and Armstrong as 
modified by Kind and King, plasma ascorbic acid is 
determined using formulae, Plasma AA in (mg/dl)= 
(OD of Ta-OD of Tb)/(OD of S2)×47.5 and plasma 
dehydroascorbic acid is determined using formulae, 
Plasma DHA in (mg/liter)=(OD of  Tb)/(OS of S)×47.5 
Observations and results 
A total of 20 healthy adult subjects’ and74 diabetic 
subjects could be studied during the period of this 
study. 
Table 1: correlation coefficients between glucose, serum zinc, alkaline phospate, ascorbic acid and 
dehydroascorbic acid parameters in controls group. 
(Control Group) 
  
Blood 
Glucoses Serum  Zn Serum AP 
Plasma 
Ascorbic 
Acid 
Plasma 
Dehydroascorbic 
Acid 
Blood glucose  Pearson 
Correlation 
                   1     
P
*
-Value      
Serum zinc  Pearson 
Correlation 
.173 1    
P
*
-Value .466     
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Serum alkaline 
phosphateses 
Pearson 
Correlation 
.135 .121 1   
P
*
-Value 
.571 
.610 
   
Plasma sscorbic 
acid 
Pearson 
Correlation 
.212 -.104 -.067 1  
P
*
-Value .369 663 .778   
Plasma dehydro 
ascorbic acid 
Pearson 
Correlation 
-.187 .145 .014 -.528
* 
1 
P
*
-Value .430 .541 .954 .017  
P
*
 value       >0.05 – Not Significant (NS)  
<0.05 – Significant (S) 
<0.001 – Highly Significant (HS) 
Table 2:correlations coefficients between glucose, serum zinc, alkaline phospate, ascorbc acid and 
dehydroascorbic acid paramitars in diabetics group. 
(Test Group) 
 
Fasting Blood 
Glucoses 
Post 
Prandial 
Blood 
Glucoses Serum  Zn Serum AP 
Plasma 
ascorbic 
acid 
Plasma 
dehydroascorbic 
acid 
Pearson 
Correlation 
1 
 
    
P
*
-value       
Pearson 
Correlation 
.641
** 1 
    
P
*
-value .001      
Pearson 
Correlation 
.279
* .099 
1    
P
*
-value 
.016 
.402  
   
Pearson 
Correlation 
.137 
.203 
-.009 1   
P
*
-value .243 .083 .941    
Pearson 
Correlation 
.271
* .297
* 
.301
** 
.104 1  
P
*
-value .019 .010 .009 .380   
Pearson 
Correlation 
.167 
.002 
.225 -108 .021 1 
P
*
-value .156 .985 .054 358 .856  
P
*
 value       >0.05 – Not Significant (NS)  
<0.05 – Significant (S) 
<0.001 – Highly Significant (HS) 
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Graph 1:-Correlation of Dehydroascorbic Acid and Plasma Ascorbic acid in Normal Control group. 
 
 
 
 
 
Graph 2:- Correlation Fasting Blood Sugar and Serum Zinc in Diabetic group. 
 
 
 
 
Graph. 3:- Correlation of  Fasting Blood Sugar and Ascorbic acid. 
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Graph. 4:- Correlation of Serum Zinc and Plasma Ascorbic Acid. 
 
Graph 5:- Correlation of Serum Zinc and Plasma Dehydroascorbic Acid. 
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Graph 6:- Correlation Plasma Dehydroascorbic Acid and Ascorbic Acid in Normal Control Group. 
 
 
 
 
 
Discussion 
 
Diabetes mellitus is a dangerous disease with 
complications and prevalence of mortality accounting 
for at least 10% of total health care[5].Three fourth of 
the world population cannot afford the products of 
allopathic medicine and thus have to resolve to the use 
of anti-diabetic evidences reported for traditional 
mediums, which are being sourced from natural 
products of animals and plants[6].The results of a study 
showed that serum aspartate amino transaminase 
(AST), alanine amino transaminase (ALT) and alkaline 
phosphatase (ALP) activity in diabetic animal groups 
(Alloxan treated rats) showed significant increase 
compared to control group. Elevated level of the 
activity of AST, ALT and ALP in blood serum is a 
strong indicator of hepatic and cardiac damage. 
Vitamin C may play an important role in physiological 
reactions such as mixed function oxidation involving 
incorporation of oxygen into a biochemical substrate. 
Zinc (Zn) is an essential trace element which is 
involved in a multitude of intracellular processes of 
more than 300 different enzymes, acting as an essential 
requirement for the successful growth of many internal 
organs, stabilizing cell membranes, and modulating 
membrane-bound enzymes and insulin action[7-9]. In 
the present series of investigation, the healthy adults 
had a fasting blood glucose level of 87.70 ± 8.90 mg/dl 
(mean ± S.D.) which is in agreement with accepted 
normal range. All the other diabetic patients were 
found to lack a very good glycemic control in spite of 
being on regular treatment. The elevation of the levels 
has been statistically found to be highly significant. 
Corroborating the above, some authors have even 
considered that the activity levels of serum Zinc and 
plasma Ascorbic acid in man. In this study the mean 
serum zinc levels were found to be lower in NIDDM 
with retinopathy and higher in all the other diabetic 
groups when compared to the mean levels in controls. 
Normal plasma zinc levels in diabetic subjects and 
found no difference related to the type of diabetes or 
therapeutic modality being employed. Corroborating 
the above, some authors have even considered that the 
activity The normal serum zinc levels in patients with 
IDDM prior to initiation of insulin treatment and the 
post treatment levels were slightly lower but still 
within normal limits levels of plasma ascorbic acid and 
plasma dehydroascorbic acid could will be an indicator 
of Zn deficiency in man. Elevated growth hormone and 
glucocorticoid production have been reported in 
diabetic states and since endogenous production or 
exogenous administration of glucocorticoids and 
growth hormone have been shown to produce 
hyperzincuria it is worth considering this as an 
important factor in producing hyperzincuria in diabetic 
states. In this study the mean serum AP levels were 
found to be higher in all the different diabetic groups. 
Low levels of serum Zn or Mg or both and reported a 
positive correlation between their levels and the peak 
activity of serum AP by these metal ions. The elevated 
circulating activity of alkaline phosphatase in alloxan 
or streptozotocin diabetes has been attributed to an 
isoenzyme of intestinal origin.an abnormal increase in 
the activity of bone specific isoenzyme in 69% of 
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diabetic, an increase in intestinal and hepatic 
isoenzymes, without any appreciable change in skeletal 
AP in alloxan diabetics in rat. It was suggested that 
elevated serum AP in DM represented an intrinsic 
feature of the diabetic condition. In this study the mean 
plasma ascorbic acid levels were found to be lower in 
the group of diabetic patients. The values of controls 
and different diabetic groups are compared. All the 
diabetic groups showed a statistically significant 
decrease in plasma ascorbic acid levels. . Corroborating 
the above, some authors have even considered that the 
activity levels of serum Zn would be an indicator of Zn 
deficiency in man. In this study the mean plasma 
dehydroascorbic acid levels were found to be higher in 
all the different diabetic group. The values of control 
and different group of diabetics are compared. As 
compared to the controls all the different diabetic 
group showed a statistically significant increase in the 
plasma DHA levels. The decreased capacity to take up, 
reduce and store AA may contribute to increased 
ascorbate turnover among diabetics and the specific 
tissue AA deficiency might contribute to the tissue 
pathology of DM. It would have been profitable to 
assess the plasma insulin levels and the residual insulin 
secreting capacities in these patients under strictly 
controlled condition or known dietary intake of the 
nutrients, their whole body and tissue status and other 
parameters glycemic index, so that a realistic 
conclusion could be drawn. Further work is being 
proposed in this regard in our laboratory. 
 
Summary and conclusion 
 
The historical discovery of insulin and efficacy in 
sustaining the life of the diabetic patients are presented. 
The long term metabolic complication and the squealer 
of DM have also been stated along with the multiplicity 
of the factors interacting. Detailed review on Zn and its 
importance in metabolism with special reference to 
DM are stated. Also developed are the aspects on the 
serum AP activity, the metabolism of AA and DHA, 
their inter relationships with glucose in health and 
Disease. The decrease in serum AA levels and the 
increase in serum DHA were highly significant. 
However, no correlations could be demonstrated 
statistically among the above said parameters in 
healthy and diabetic subjects within the limitations of 
the present study. It is being speculated that the raised 
serum AP activity may be due to the de-inhibition of 
activity by lowered serum AA concentrations. The 
likely shortfall in the study for lack of demonstrable 
correlations is discussed. The right for eating, exercise 
and right thinking needs to be stressed, particularly for 
diabetics. Serum Alkaline Phosphatase activity is 
eliminated in diabetics. It is an indicator of liver 
function that may be hampered in long term in 
diabetics. Serum Ascorbic acid is an antioxidant and its 
levels are decreased in diabetics. Its values can be 
assayed for monitoring oxidative reaction in diabetics. 
The estimation of serum zinc is not needed as there is 
no statistical difference. 
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